Stock Groups

Clariant delays 2021 results amid accounting probe -Breaking

by Mike Robinson

[ad_1]

© Reuters. FILE PHOTO – The logo for Clariant, a Swiss specialty chemical company is seen in the company’s Pratteln headquarters on August 9, 2017. REUTERS/Arnd Wiegmann

ZURICH (Reuters). Clariant has delayed the publication of 2021 results, while an independent investigation examines allegations made by whistleblowers about improper booking of accruals and provisions during 2020 and 2021.

Clariant believes it can achieve its EBITDA margin guidance between 16-17% in continuing operations for 2021. The company’s annual sales rose 15% to 4.37 billion Swiss Francs ($4.72billion), preliminary data show.

($1 = 0.9252 Swiss francs)

Disclaimer: Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs are stocks, futures, indexes or Forex. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. Because prices might not reflect the market, they may be incorrect. This means that prices cannot be considered indicative and are inappropriate for trading. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.

[ad_2]